AimwellBio Continues Onboarding Healthcare Professionals to Its Verified Observer Network, Adds One-Click LinkedIn SignupAimwell Partners Inc. (OTC PINK:AIMN) is actively onboarding doctors, scientists, researchers, and capital professionals into AimwellBio Observer, a credentialed intelligence network where members read source-traced signals across biopharma. A new LinkedIn connect flow makes applying faster. Complimentary access is currently available for approved professionals. Credentialing required.
AIMN: As Healthcare Breaches Hit a Record and Move to Third-Party Providers, AimwellBio.com Explores a Redundancy Layer Built to Survive the VendorWith over one billion Americans' health records now breached and the largest incidents shifting to mission-critical third parties, Aimwell Partners Inc. is exploring verified infrastructure that adds redundancy rather than another patch
AimwellBio Expands Platform Capabilities to Strengthen the Infrastructure Behind Trusted Healthcare IntelligenceDENVER, CO / ACCESS Newswire / June 17, 2026 / Aimwell Partners Inc. (OTCID:AIMN) today announced an expansion of technical capabilities supporting AimwellBio, the Company's healthcare intelligence platform focused on verified professional participation and trusted decision intelligence.
